Explore our library of archived lectures on solid tumors from The Science of Childhood Cancer hosted by the St. Jude Comprehensive Cancer Center. Please register for updates on upcoming virtual events.
Solid tumor lectures
-
Developmental programs contribute to chemoresistance in pediatric solid tumors
11/14/2024
Michael Dyer, PhD
Chair, Developmental Neurobiology Department
Co-Leader, Developmental Biology & Solid Tumor Program
Richard C. Shadyac Endowed Chair in Pediatric Cancer Research
Investigator, Howard Hughes Medical Institute -
Addressing the challenges of HPV vaccination in young cancer survivors
10/31/2024
Wendy Landier, PhD, CRNP
Professor, Pediatric Hematology/Oncology
University of Alabama at Birmingham -
Developmental heterogeneity in rhabdomyosarcoma
10/17/2024
Mark Hatley, MD, PhD
Associate Member
Director Division of Molecular Oncology
Department of Oncology -
Wild type and mutant p53 functions
08/29/2024
Guillermina Lozano, PhD
Chair, Department of Genetics
The University of Texas MD Anderson Cancer Center -
Engineered Cell Therapy for Pediatric Cancer
08/08/2024
Stephen Gottschalk, MD
Chair, Department of Bone Marrow Transplantation and Cellular Therapy
Co-Director, Center of Excellence for Pediatric Immuno-Oncology
St. Jude Children's Research Hospital -
Rising Stars of Cancer Research
03/07/2024
Dissecting epigenetic control of transcription in pediatric cancer
Adam Durbin, MD, PhD
St. Jude Childrens Research Hospital
Organoids in pediatric cancer research
Jarno Drost, PhD
Princess Máxima Center for Pediatric Oncology
Oncode Institute -
Neuroblastoma: The power of immunotherapy in pediatric malignancy
11/02/2023
Julie Park, MD
St. Jude Children's Research Hospital -
Genomic analysis of osteosarcoma: Making sense of a complex genome to advance translational research and targeted therapy
10/05/2023
Alejandro Sweet-Cordero, MD
University of California-San Francisco -
Advancing Outcomes for Patients with Neuroblastoma
09/21/2023
Sara Federico, MD
St. Jude Children's Research Hospital -
Childhood neuroblastoma: evolution and malignant progression
09/14/2023
Frank Westermann, MD
German Cancer Research Center (DKFZ)
Hopp Children’s Cancer Center (KiTZ)
Heidelberg, Germany -
Pushing for new biology and cancer therapies in rhabdomyosarcoma
09/07/2023
David Langenau, PhD
Harvard Medical School
Mass General Cancer Center and Pathology -
Mechanisms of chromatin regulation by EWS fusion proteins
04/06/2023
Miguel N. Rivera, MD
Harvard Medical School
Massachusetts General Hospital -
Discovering and Targeting Neuroblastoma Vulnerabilities: ALK Inhibition as a Paradigm
03/03/2022
Yaël Mossé, MD
Perelman School of Medicine
University of Pennsylvania
Children's Hospital of Philadelphia -
Chimeric Antigen Receptor-Redirected Macrophages for the Treatment of Solid Tumors
10/07/2021
Saar Gill, MBBS, PhD, FRACP
University of Pennsylvania Perelman School of Medicine -
Sunlight and Skin: Lessons for Melanoma Therapeutics From Its Unique Pathogenesis
09/23/2021
David E. Fisher MD, PhD
Massachusetts General Hospital
Harvard Medical School -
Modulation of the Activity of the Dominant Oncogene EWS-FLI1 by Germline Polymorphisms and Cohesin Mutations
08/26/2021
Olivier Delattre, MD, PhD
Institut Curie, Paris, France -
Identification of Biomarkers, Models and Targets to Improve Outcomes and Precision Approaches for Neuroblastoma
08/19/2021
Meredith Irwin, MD
University of Toronto -
Structure and Function of Mammalian SWI/SNF Chromatin Remodeling Complexes in Human Cancer
05/06/2021
Cigall Kadoch, PhD
Dana-Farber Cancer Institute and Harvard Medical School -
A First-generation Pediatric Cancer Dependency Map
04/29/2021
Kimberly Stegmaier, MD
Harvard Medical School
Dana-Farber Cancer Institute -
Harnessing Lineage Plasticity for the Treatment of Neuroblastoma
10/29/2020
Rani George MD, PhD
Dana-Farber Cancer Institute/Boston Children's Hospital -
Chromatin Remodeler Mutations in Cancer: Mechanisms and Therapeutic Vulnerabilities
08/20/2020
Charles W.M. Roberts, MD, PhD
St. Jude Children's Research Hospital
Comprehensive Cancer Center
St. Jude is the first and only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children.
